NCT05110664View on ClinicalTrials.gov

APPETITE: linguAl PYY3-36 on aPpEtite and acuTe Energy InTakE

UnknownOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

August 31, 2022

Study Completion Date

October 31, 2022

Conditions

Obesity

Interventions

DRUG

PYY (3-36) Peptide

oral PYY3-36 solution

DRUG

Placibo

oral placebo solution

Sponsors

Collaborators (1)

Gila Therapeutics, Inc.

All Listed Sponsors

collaborator

Gila Therapeutics, Inc.

INDUSTRY

lead

University College, London

OTHER

NCT05110664 - APPETITE: linguAl PYY3-36 on aPpEtite and acuTe Energy InTakE | Biotech Hunter | Biotech Hunter